Appetite clinical trials

Explore recruiting appetite clinical trials.

Recruiting appetite studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Appetite trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of the appetite-inducing hormone ghrelin on decision making in healthy volunteers

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

INCREDIBLE: INCREmental DIalysis and diet for a Better Life Experience; Clinical relevance of an “add-on” Ketosteril supplementation on incremental haemodialysis period in incident haemodialysis patients. An exploratory randomized controlled trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

C3651003 A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENTS WITH CANCER, CACHEXIA, AND ELEVATED CONCENTRATIONS OF GDF-15, FOLLOWED BY AN OPTIONAL OPEN-LABEL TREATMENT PERIOD (PROACC -1)

Bulgaria, Poland, Spain, Slovakia

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of an adjunctive intervention on the tolerability of semaglutide in overweight adults without diabetes: a prospective, randomised, double-blind, single-centre, placebo-controlled clinical trial (SEMTOL)

Estonia

Therapeutic use (Phase IV) EU CTIS Study details

A study of how CagriSema works on appetite in people with excess body weight

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012).

Poland, Spain, Netherlands, Italy, Finland, Romania +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Appetite trials by city

Appetite in Toronto Appetite in Vancouver Appetite in Montreal Appetite in Calgary Appetite in Edmonton Appetite in Ottawa Appetite in Winnipeg Appetite in Quebec City Appetite in Hamilton Appetite in Kitchener Appetite in London Appetite in Halifax Appetite in New York Appetite in Los Angeles Appetite in Chicago Appetite in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease